Vladislav Shestakov: “I am sure that we can create a true world blockbuster”
May 24, 2018 in St. Petersburg Head of the FSI “SID & GP” of the Ministry of Industry and Trade of Russian Federation Vladislav Shestakov at the round table “Pharmaceutical industry. How to ensure growth and innovation “highlighted the main priority for the development of the pharmaceutical industry of the future:” It is worth paying attention to new directions, such as personalized medicine, digital pharmacy, telemedicine, etc. I am sure that we can create a real world blockbuster. “
The round table was held by the non-profit partnership “Pharmaceutical Business Club”, which unites the major medicines` producing companies operating in the Russian Federation during the St. Petersburg International Economic Forum (SPIEF 2018).
The event was attended by Deputy Minister of Industry and Trade of the Russian Federation Sergey Tsyb, the Head of Roszdravnadzor Mikhail Murashko, Director of the FSI “SID & GP” of the Ministry of Industry and Trade of the Russian Federation Vladislav Shestakov, heads of public authorities and constituent entities of the Russian Federation, Russian and foreign pharmaceutical companies, research centers, industry experts.
In the framework of the round table a discussion of the very important and relevant to the industry and its development issues took place, including the investment attractiveness of regions, issues of international cooperation in support of the export development, innovative development in the field of pharmaceuticals, the formation of the suggestions to the program “Pharma 2030”, training of the young personnel.
Also, the participants of the round table addressed an extremely important topic – the production of innovative medicines. It is where Vladislav Shestakov expressed the commonly shared view that “this type of products will be a driver for the development of the Russian pharmaceutical industry when the shift of the production vector from long-term circulation outdated generic drugs on the pharmaceutical market to the production of the most modern and important drugs for the Russian medicine “. Director of the FSI “SID & GP” of the Ministry of Industry and Trade of the Russian Federation noted the importance of localization of innovative productions of world leaders of the pharmaceutical industry in Russia, and a company spokesperson, “Takeda” Ilya Wesker shared with participants the successful experience of the company in this matter, “there has been a new trend in innovative production in the Russian pharmaceutical industry preparations on the basis of original developments. We have taken into account the needs of the scientific community in the field of preparations for the treatment of orphan diseases and by the end of this year, we will begin the production of our innovative drug “Ninlaro” at our production site in the Yaroslavl region. “
The results of the round table summarized the Deputy Minister of Industry and Trade of the Russian Federation Sergey Tsyb, noting the importance of this event: “I urge colleagues not to postpone the issues that we discussed today on the back burner. As you know, now the Ministry (the Ministry of Industry and Trade of the Russian Federation) is working on the strategy for the development of the industry until 2030, so we are waiting for your suggestions and are ready to work on them. “In addition, Sergei Tsyb noted the extreme importance of training highly qualified personnel for the pharmaceutical industry. “Only bright people can make innovative products”, – said the Deputy Minister, and expressed readiness to support in conjunction with the FSI “SID & GP” Russian Ministry’s educational programs, including upcoming GxP summit with international participation “Choice of the best. Time forward “, which will be held in Sochi (Rosa Khutor) from 3 to 6 July 2018.
- Annual Biotechmed Forum: State Institute of Drugs and Good Practices presents survey results of drug manufacturers’ preparedness for comprehensive labeling
- The State Institute of Medicines and Good Practices concludes strategic agreements at the annual Biotechmed Forum
- Russian Ministry of Industry and Trade and State Institute of Drugs and Good Practices took part in International Conference of Drug Regulatory Authorities
- SID & GP strengthens interaction between international regulators
- Presentation at ISPE conference in Singapore